{"component": "definition", "props": {"groups": [{"snippet_links": [], "size": 411, "samples": [{"hash": "kdO5ZNnvdcB", "uri": "/contracts/kdO5ZNnvdcB#cmc", "label": "Collaboration and License Agreement (4D Molecular Therapeutics, Inc.)", "score": 37.2080764771, "published": true}, {"hash": "2hRFsFyr0ao", "uri": "/contracts/2hRFsFyr0ao#cmc", "label": "License Agreement (Atrium Therapeutics, Inc.)", "score": 37.1560592651, "published": true}, {"hash": "huXnGMLo1xQ", "uri": "/contracts/huXnGMLo1xQ#cmc", "label": "License and Collaboration Agreement (Mannkind Corp)", "score": 37.1533203125, "published": true}], "snippet": "means chemistry, manufacturing and controls.", "hash": "cdd856b6e6c365879a8cce9ac127808a", "id": 1}, {"snippet_links": [{"key": "comprehensive-maintenance-contract", "type": "definition", "offset": [6, 40]}, {"key": "preventive-maintenance", "type": "clause", "offset": [75, 97]}], "size": 184, "samples": [{"hash": "fX7pSNsZrhF", "uri": "https://icar-nrri.in/wp-content/uploads/2021/01/2.-LaboratoryWorkingTable-1.pdf", "label": "icar-nrri.in", "score": 15.9401035309, "published": false}, {"hash": "eV0QkU3eCCg", "uri": "https://icar-nrri.in/wp-content/uploads/2021/01/3.-ThermalCycler.pdf", "label": "icar-nrri.in", "score": 15.8403234482, "published": false}, {"hash": "1CI93qxoZut", "uri": "https://icar-nrri.in/wp-content/uploads/2020/06/AutomatedTitrator.272.pdf", "label": "icar-nrri.in", "score": 15.2649068832, "published": false}], "snippet": "means Comprehensive Maintenance Contract (Including all spares, labour and preventive maintenance)", "hash": "6baba5ef26391dfafe59e02fa4992e88", "id": 2}, {"snippet_links": [{"key": "comprehensive-maintenance-contract", "type": "definition", "offset": [6, 40]}, {"key": "preventive-maintenance", "type": "clause", "offset": [60, 82]}], "size": 121, "samples": [{"hash": "kzo2XrRV1Mq", "uri": "http://www.hsccltd.co.in/images/tender/BidDocSjf%2034%2029.9.2017%20part%201.pdf", "label": "www.hsccltd.co.in", "score": 20.0719490051, "published": false}, {"hash": "1mj6gzSawie", "uri": "http://ftp.hsccltd.co.in/images/tender/Part%20A%20SJH_ME-41_14-03-18.pdf", "label": "ftp.hsccltd.co.in", "score": 19.5409526825, "published": false}, {"hash": "85PeEzDAY4G", "uri": "http://hsccltd.com/images/tender/Tender_Document_Raebareli07_04-09-2020.pdf", "label": "hsccltd.com", "score": 15.522400856, "published": false}], "snippet": "means Comprehensive maintenance Contract (labour, spare and preventive maintenance)", "hash": "44666424347ad7387721a0ac030bbc35", "id": 3}, {"snippet_links": [{"key": "as-required", "type": "clause", "offset": [62, 73]}, {"key": "regulatory-authority", "type": "clause", "offset": [91, 111]}, {"key": "relating-to", "type": "definition", "offset": [112, 123]}, {"key": "drug-products", "type": "definition", "offset": [169, 182]}], "size": 40, "samples": [{"hash": "fZrtfvQpEFb", "uri": "/contracts/fZrtfvQpEFb#cmc", "label": "Warrant Purchase Agreement (Exelixis Inc)", "score": 21.591375351, "published": true}, {"hash": "fjFlkkVu3vE", "uri": "/contracts/fjFlkkVu3vE#cmc", "label": "Purchase Option Agreement (Dynavax Technologies Corp)", "score": 21.2026004791, "published": true}, {"hash": "dWG7qywWpDj", "uri": "/contracts/dWG7qywWpDj#cmc", "label": "Purchase Option Agreement (Symphony Capital Partners LP)", "score": 21.0273780823, "published": true}], "snippet": "means the chemistry, manufacturing and controls documentation as required for filings with Regulatory Authority relating to the manufacturing, production and testing of drug products.", "hash": "20a999d78fd1a3014e65218fb1a31380", "id": 4}, {"snippet_links": [{"key": "term-of", "type": "clause", "offset": [53, 60]}], "size": 36, "samples": [{"hash": "ltYRUy1DaB5", "uri": "/contracts/ltYRUy1DaB5#cmc", "label": "Clinical Trial Collaboration and Supply Agreement (Bicara Therapeutics Inc.)", "score": 35.4394264221, "published": true}, {"hash": "ljaEN1aTlqH", "uri": "/contracts/ljaEN1aTlqH#cmc", "label": "Clinical Trial Collaboration and Supply Agreement (BioLineRx Ltd.)", "score": 33.2026023865, "published": true}, {"hash": "gjrZOBRjswG", "uri": "/contracts/gjrZOBRjswG#cmc", "label": "Clinical Trial Collaboration and Supply Agreement (IO Biotech, Inc.)", "score": 32.928817749, "published": true}], "snippet": "means \u201cChemistry Manufacturing and Controls\u201d as such term of art is used in the pharmaceutical industry.", "hash": "d435ec50946f0e39ede17169d8873bc8", "id": 5}, {"snippet_links": [], "size": 35, "samples": [{"hash": "hoq3w2i3sgu", "uri": "/contracts/hoq3w2i3sgu#cmc", "label": "Manufacturing Services Agreement (Evoke Pharma Inc)", "score": 35.3655014038, "published": true}, {"hash": "4xqha4erQ4x", "uri": "/contracts/4xqha4erQ4x#cmc", "label": "Manufacturing Services Agreement (Evoke Pharma Inc)", "score": 35.1984939575, "published": true}, {"hash": "9AeWehSapia", "uri": "/contracts/9AeWehSapia#cmc", "label": "Master Manufacturing Services Agreement (Acadia Pharmaceuticals Inc)", "score": 35.1574249268, "published": true}], "snippet": "has the meaning specified in Section 7.8(c);", "hash": "a2b3803bff4aae464809a4fca7113c63", "id": 6}, {"snippet_links": [{"key": "customer-management", "type": "clause", "offset": [10, 29]}, {"key": "communications-provider", "type": "definition", "offset": [100, 123]}, {"key": "a-site", "type": "definition", "offset": [160, 166]}, {"key": "terms-of", "type": "clause", "offset": [177, 185]}, {"key": "facilities-services", "type": "clause", "offset": [225, 244]}], "size": 23, "samples": [{"hash": "4tlLWhrjYAX", "uri": "/contracts/4tlLWhrjYAX#cmc", "label": "Contract", "score": 30.0029602051, "published": true}, {"hash": "eutXU3vXB1f", "uri": "/contracts/eutXU3vXB1f#cmc", "label": "Service Agreement", "score": 27.320892334, "published": true}, {"hash": "7J4CtbAnm1a", "uri": "/contracts/7J4CtbAnm1a#cmc", "label": "Telecommunications", "score": 26.2177314758, "published": true}], "snippet": "means the Customer Management Centre nominated by BT; \u201cCo-location\u201d which is an arrangement for the Communications Provider to occupy co-location facilities at a Site under the terms of a Revised Agreement for Access Network Facilities Services;", "hash": "6a107c936d1d45b09e713d46f39048c1", "id": 7}, {"snippet_links": [{"key": "regulatory-filing", "type": "definition", "offset": [64, 81]}], "size": 19, "samples": [{"hash": "iWX7FNj2A6l", "uri": "/contracts/iWX7FNj2A6l#cmc", "label": "License and Collaboration Agreement (LianBio)", "score": 34.2347717285, "published": true}, {"hash": "957F4wASNpd", "uri": "/contracts/957F4wASNpd#cmc", "label": "License and Collaboration Agreement (Lyra Therapeutics, Inc.)", "score": 32.603012085, "published": true}, {"hash": "dqx1nA5AtKY", "uri": "/contracts/dqx1nA5AtKY#cmc", "label": "License and Collaboration Agreement (Landos Biopharma, Inc.)", "score": 32.57289505, "published": true}], "snippet": "means the Chemistry, Manufacturing, and Controls portion of any Regulatory Filing.", "hash": "7975f165dd74fd1091ccdd54be25f971", "id": 8}, {"snippet_links": [{"key": "development-records", "type": "clause", "offset": [85, 104]}, {"key": "for-products", "type": "clause", "offset": [105, 117]}, {"key": "control-procedures", "type": "clause", "offset": [156, 174]}, {"key": "necessary-for", "type": "definition", "offset": [175, 188]}, {"key": "manufacture-of-products", "type": "clause", "offset": [189, 212]}, {"key": "raw-materials-and-components", "type": "clause", "offset": [250, 278]}], "size": 18, "samples": [{"hash": "5Rf7buiSjht", "uri": "/contracts/5Rf7buiSjht#cmc", "label": "Strategic Collaboration and License Agreement (Metagenomi Technologies, LLC)", "score": 35.0095825195, "published": true}, {"hash": "aeeFDr6sD3n", "uri": "/contracts/aeeFDr6sD3n#cmc", "label": "Mrna Cancer Vaccine Collaboration and License Agreement (Moderna, Inc.)", "score": 29.8542098999, "published": true}, {"hash": "h8TvRT5YTfq", "uri": "/contracts/h8TvRT5YTfq#cmc", "label": "Mrna Cancer Vaccine Collaboration and License Agreement (Moderna, Inc.)", "score": 29.659822464, "published": true}], "snippet": "means Chemistry and Manufacturing Controls, which includes (a) Manufacturing process development records for products, (b) all chemistry, Manufacturing and control procedures necessary for Manufacture of products, and (c) sourcing and testing of all raw materials and components used in the Manufacture of products.", "hash": "bf4640d04594251a6e73f54010880415", "id": 9}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [44, 59]}, {"key": "licensed-compound", "type": "definition", "offset": [64, 81]}, {"key": "licensed-products", "type": "definition", "offset": [85, 102]}], "size": 15, "samples": [{"hash": "fkP5EGylVFd", "uri": "/contracts/fkP5EGylVFd#cmc", "label": "License and Collaboration Agreement (Crescent Biopharma, Inc.)", "score": 37.0164260864, "published": true}, {"hash": "74vbN85LtfB", "uri": "/contracts/74vbN85LtfB#cmc", "label": "License and Collaboration Agreement (BioNTech SE)", "score": 35.2149200439, "published": true}, {"hash": "cil9q5wggq5", "uri": "/contracts/cil9q5wggq5#cmc", "label": "License and Collaboration Agreement (BioNTech SE)", "score": 34.2149200439, "published": true}], "snippet": "means chemistry, manufacturing and controls with respect to the Licensed Compound or Licensed Products.", "hash": "2a8311e75fca3215e34853c7130abc82", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMY21jIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "CMC", "size": 1581, "snippet": "means chemistry, manufacturing and controls.", "id": "cmc", "examples": ["The Parties will exchange information, share Records and make written progress reports as necessary or useful related to pre-clinical, clinical, <strong>CMC</strong> and all other dossier-related materials, data and information.", "Likewise, NVP is allowed to cross-reference <strong>CMC</strong>, documentation and regulatory filings controlled by YUNGJIN for the Licensed Compound and Licensed Product in the Retained Territory without any financial consideration.", "NVP will provide medicinal chemistry, as well as formulation and other <strong>CMC</strong> aspects input as appropriate for the Licensed Compound in the Territory.", "For the purpose of YUNGJIN\u2019s development in the Retained Territory, YUNGJIN is allowed to cross-reference and use <strong>CMC</strong>, documentation and regulatory filings controlled by NVP for the Licensed Product in the Territory without any financial consideration."], "related": [["dsm", "DSM", "DSM"], ["apc", "APC", "APC"], ["tdp", "TDP", "TDP"], ["cti", "CTI", "CTI"], ["fis", "FIS", "FIS"]], "related_snippets": [], "updated": "2026-04-15T04:23:14+00:00"}, "json": true, "cursor": ""}}